SCHEMBL13626351

SCHEMBL13626351

CCN(Cc1ccc(OC2CCC3CCC(C2)N3C)c(F)c1)c1cc(O)ccc1C1CCc2cc(O)ccc2C1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.50
ESR2 Q92731 1/20 0.50
CHRM1 P11229 5/20 0.33
CHRM3 P20309 5/20 0.33
CHRM5 P08912 1/20 0.33
MCHR1 Q99705 4/20 0.31
KCNH2 Q12809 1/20 0.31
CHRM2 P08172 4/20 0.31
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30
DRD2 P14416 1/20 0.30
DRD4 P21917 1/20 0.30
DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL224310 0.97 ESR1 (0.51) ESR1ESR2CHRM1CHRM3CHRM5
SCHEMBL230283 0.85 ESR1 (0.52) ESR1ESR2CHRM1CHRM3CHRM5
SCHEMBL227075 0.84 ESR1 (0.62) ESR1ESR2CHRM1CHRM3CHRM5
SCHEMBL227076 0.84 ESR1 (0.62) ESR1ESR2CHRM1CHRM3CHRM5
SCHEMBL226262 0.82 ESR1 (0.50) ESR1ESR2CHRM1CHRM3CHRM5
SCHEMBL226261 0.82 ESR1 (0.50) ESR1ESR2CHRM1CHRM3CHRM5
SCHEMBL225109 0.81 ESR1 (0.68) ESR1ESR2CHRM1CHRM3CHRM5
SCHEMBL226934 0.81 ESR1 (0.61) ESR1ESR2MCHR1DRD2DRD3
SCHEMBL226933 0.81 ESR1 (0.61) ESR1ESR2MCHR1DRD2DRD3
SCHEMBL229188 0.81 ESR1 (0.51) ESR1ESR2CHRM1CHRM3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed